Search Results1-20 of  20

  • NAGASAWA Hayato ID: 9000001333372

    Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University (2012 from CiNii)

    Articles in CiNii:7

    • Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis : a better response in male patients (2004)
    • Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab (2006)
    • Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J) (2008)
  • NAGASAWA Hayato ID: 9000003766097

    Articles in CiNii:12

    • カルシニューリン阻害薬の使い方 (2009)
    • Clinical significance of serum matrix metalloproteinase-3 level in patients with rheumatoid arthritis (2005)
    • 関節リウマチに対する分子標的治療薬--インフリキシマブ,エタネルセプト (特集 基礎から学ぶ分子標的治療薬) -- (ターゲットと作用機序) (2007)
  • NAGASAWA Hayato ID: 9000240536365

    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University (2012 from CiNii)

    Articles in CiNii:1

    • Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors (2012)
  • NAGASAWA Hayato ID: 9000259336789

    Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University (2013 from CiNii)

    Articles in CiNii:1

    • A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology (2013)
  • NAGASAWA Hayato ID: 9000259336803

    The Ad Hoc Committee for the Safety of Biological DMARDs, Japan College of Rheumatology (2013 from CiNii)

    Articles in CiNii:1

    • Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis : a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs (2013)
  • NAGASAWA Hayato ID: 9000259337064

    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University (2013 from CiNii)

    Articles in CiNii:1

    • Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis (2013)
  • Nagasawa Hayato ID: 9000021930960

    Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University (2009 from CiNii)

    Articles in CiNii:1

    • Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases (2009)
  • Nagasawa Hayato ID: 9000022057744

    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Japan (2012 from CiNii)

    Articles in CiNii:1

    • A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease (2012)
  • Nagasawa Hayato ID: 9000237823985

    Articles in CiNii:1

    • Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules (2012)
  • Nagasawa Hayato ID: 9000240055877

    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Japan (2013 from CiNii)

    Articles in CiNii:1

    • Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide (2013)
  • Nagasawa Hayato ID: 9000311769171

    Graduate school of science and technology Nihon University (2015 from CiNii)

    Articles in CiNii:1

    • B-7-37 Video Content Individualization based on Quasi-digital Watermarking (2015)
  • Nagasawa Hayato ID: 9000323290984

    Articles in CiNii:1

    • Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: Results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry (2015)
  • Nagasawa Hayato ID: 9000345196326

    Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University (2008 from CiNii)

    Articles in CiNii:1

    • Management of patients who have failed in the treatment with the first biological agent (2008)
  • Nagasawa Hayato ID: 9000391408667

    Division of Rheumatology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University (2007 from CiNii)

    Articles in CiNii:1

    • Prevention of radiological progression by biological agents in rheumatoid arthritis (2007)
  • Nagasawa Hayato ID: 9000391775871

    埼玉医科大学総合医療センター リウマチ・膠原病内科 (2008 from CiNii)

    Articles in CiNii:1

    • 関節リウマチ患者におけるinfliximabに対する免疫反応とFcγ receptor IIIA遺伝子多型との関連 (2008)
  • Nagasawa Hayato ID: 9000391776723

    Articles in CiNii:1

    • 関節リウマチに対するタクロリムスの有用性 (2006)
  • Nagasawa Hayato ID: 9000391776967

    埼玉医科大学総合医療センターリウマチ/膠原病内科 (2006 from CiNii)

    Articles in CiNii:1

    • 末梢血TNF-α産生能を指標としたインフリキシマブ有効性予測に関する検討 (2006)
  • Nagasawa Hayato ID: 9000391778030

    Division of Rheumatology / Clinical Immunology, Department of Internal Medicine , Saitama medical center (2007 from CiNii)

    Articles in CiNii:1

    • Discriminating factors between responder and non-responder in infliximab-treated patients with rheumatoid arthritis (2007)
  • Nagasawa Hayato ID: 9000391781065

    Articles in CiNii:1

    • インフリキシマブ投与関節リウマチ症例における抗CCP抗体価の推移と臨床的意義 (2009)
  • Nagasawa Hayato ID: 9000391781087

    埼玉医科大学総合医療センター リウマチ・膠原病内科 (2009 from CiNii)

    Articles in CiNii:1

    • 関節リウマチ患者におけるinfliximabの注射時反応とFcγ receptor III遺伝子多型との関連 (2009)
Page Top